Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
about
Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.Statin use and breast cancer survival and risk: a systematic review and meta-analysisDo renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studiesEffects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals.Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis.Risk of Alzheimer's disease or dementia following a cancer diagnosis.Statins and breast cancer prognosis: evidence and opportunities.Metabolic syndrome and outcomes following early-stage breast cancer.Associations between diabetes medication use and risk of second breast cancer events and mortalityUse of Antihypertensive Medications Not Associated with Risk of Contralateral Breast Cancer among Women Diagnosed with Estrogen Receptor-Positive Invasive Breast Cancer.Statin use and breast cancer survival: a nationwide cohort study in Scotland.Breast cancer recurrence in relation to antidepressant use.Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.Statins and risk of breast cancer recurrence.High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer.Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-Medicare population.Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.The interplay between cell signalling and the mevalonate pathway in cancer.De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancerCharacteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.Impact of Statin Use on Outcomes in Triple Negative Breast CancerEffect of statins on breast cancer recurrence and mortality: a review.Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database.Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study.Statin Use and Breast Cancer Prognosis in Black and White Women.Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.Interactions Between Genotype and Preoperative Statin Use Impact Clinical Outcomes Among Breast Cancer Patients
P2860
Q27331637-51564E97-036D-443E-B04A-5BBD6702582DQ28082068-8477FA13-664C-4900-8629-DA41032A33FBQ30235047-3F0F450B-D963-4ED4-B95E-C8A0B6C6041AQ30241078-B1E552DA-049B-4ECC-A693-81FA2AF47479Q30250324-15A24448-7D2C-4B8E-9E93-275D61D7F911Q33817462-FA145D0C-8627-4955-B329-3877A651F181Q34206487-0023B68A-6A9F-475A-8E14-BBDA43B641F1Q34539016-D990A988-4C07-493D-85E5-8688B82D1226Q35850213-CBE3F1F3-82AA-4CDD-B625-790E0D27D42AQ36029475-536105B7-4595-49B6-A7E5-73C6882FFCC0Q36095264-5B53B7CA-4288-47EB-ADF5-5F0AF97FEA6BQ37020150-56ADA39D-132D-4A4B-9036-9DD627FA08E6Q37228939-08D07738-98D1-4872-B3CC-9A17B0732A9CQ37407449-5ABFB98E-141F-496F-8772-99E335D02106Q37644912-725D2879-C852-4895-97CE-50A22735518AQ38625054-DC650729-6522-42A2-AE0F-32E06CD51657Q38750495-708E0309-D9E5-4D32-9A4F-E6AE8FCFC614Q38879569-86A67D21-6B13-4F31-B535-E01E4EA0CF5CQ38937455-F4A92DB2-09E9-4E3D-946F-03A235D4B23BQ39534421-81C22F4B-B9AD-42D6-882E-3B68937EB0F5Q40483088-0D9AE410-3CDA-4313-ADE4-342589979274Q41439871-29903B2A-1264-4725-B58B-4715BA8ED708Q47108341-EF08DA9E-36F8-40EB-8B5F-9F47A0734324Q47372688-9CFE1634-F776-47E9-ADE7-E1CB00AF4FFBQ47602572-2B050596-5C10-4A4B-82A1-95D2B47CDA06Q47755766-A3A59CCE-AE4B-4324-8A7F-FF97A6BB48A7Q47863448-40065BF4-5A4F-4BF9-AF1A-C4D0280E6E5AQ50899870-428068BD-07A5-4F76-B7E4-8D8E76294EEFQ58122649-EE7BA2D0-7E2F-428E-9FC8-81E8EDADB452
P2860
Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative safety of cardiova ...... ith early stage breast cancer.
@en
Comparative safety of cardiova ...... ith early stage breast cancer.
@nl
type
label
Comparative safety of cardiova ...... ith early stage breast cancer.
@en
Comparative safety of cardiova ...... ith early stage breast cancer.
@nl
prefLabel
Comparative safety of cardiova ...... ith early stage breast cancer.
@en
Comparative safety of cardiova ...... ith early stage breast cancer.
@nl
P2093
P2860
P1476
Comparative safety of cardiova ...... ith early stage breast cancer.
@en
P2093
Denise M Boudreau
Diana S M Buist
Erin J Aiello Bowles
Heidi S Wirtz
Jessica Chubak
Monica Fujii
P2860
P2888
P304
P356
10.1007/S10549-014-2870-5
P407
P577
2014-02-21T00:00:00Z